Milrinone on Cardiac Performance During Off-pump Coronary Artery Bypass Surgery
NCT ID: NCT04153383
Last Updated: 2023-09-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
20 participants
OBSERVATIONAL
2024-09-30
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Trial of Tranexamic Acid in Cardiac Surgery
NCT01998438
Prophylactic Administration of Levosimendan in Patients Undergoing Coronary Surgery
NCT01318460
Comparison of Milrinone and Epinephrine on TAPSE
NCT07144267
MInithoraCotomy vs Sternotomy for Multivessel Coronary Artery Bypass Grafting: A Partially Randomized Patient Preference Trial Assessing Quality of Life and Patency Outcomes
NCT04795193
Study of NU172 as Anticoagulation in Patients Undergoing Off-pump CABG Surgery
NCT00808964
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TMAD
Tissue motion annular displacement (TMAD) of tricuspid valve annulus transesophageal echocardiography
Milrinone Injection
giving IV milrinone: 50 mcg/kg loading dose by IV push over 10 minutes, then 0.375-0.75 mcg/kg/min IV
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Milrinone Injection
giving IV milrinone: 50 mcg/kg loading dose by IV push over 10 minutes, then 0.375-0.75 mcg/kg/min IV
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient undergoing elective coronary artery bypass graft surgery
* preoperative LV EF\>50% (TTE)
Exclusion Criteria
* preoperative IABP
* use of other inotropic agents
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Konkuk University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tae-Yop Kim, MD PhD
Professor of Anesthesiology
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KUH0000000123
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.